JPS63192795A - ６β，１１α−ジヒドロキシ−４−アンドロステン−３，１７−ジオン - Google Patents
６β，１１α−ジヒドロキシ−４−アンドロステン−３，１７−ジオンInfo
- Publication number
- JPS63192795A JPS63192795A JP62024595A JP2459587A JPS63192795A JP S63192795 A JPS63192795 A JP S63192795A JP 62024595 A JP62024595 A JP 62024595A JP 2459587 A JP2459587 A JP 2459587A JP S63192795 A JPS63192795 A JP S63192795A
- Authority
- JP
- Japan
- Prior art keywords
- androstene
- dione
- dihydroxy
- methanol
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SNJPACUKNSUSKE-YPIFDJLOSA-N (6r,8s,9s,10r,11r,13s,14s)-6,11-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3[C@H](O)C[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3C[C@@H](O)C2=C1 SNJPACUKNSUSKE-YPIFDJLOSA-N 0.000 title description 7
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 claims abstract description 7
- 229960005471 androstenedione Drugs 0.000 claims abstract description 6
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract description 7
- 239000000758 substrate Substances 0.000 abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 6
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 6
- 206010006187 Breast cancer Diseases 0.000 abstract description 5
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 102000014654 Aromatase Human genes 0.000 abstract description 4
- 108010078554 Aromatase Proteins 0.000 abstract description 4
- 241000228417 Sarocladium strictum Species 0.000 abstract description 3
- 239000001963 growth medium Substances 0.000 abstract description 3
- 239000006228 supernatant Substances 0.000 abstract description 3
- 238000001819 mass spectrum Methods 0.000 abstract description 2
- 238000002844 melting Methods 0.000 abstract description 2
- 230000008018 melting Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 5
- 150000001443 androstenes Chemical class 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 210000002826 placenta Anatomy 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000009422 growth inhibiting effect Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229960001603 tamoxifen Drugs 0.000 description 2
- UDHAKZRCGHAPAZ-NFBMXZEVSA-N (6r,8r,9s,10r,13s,14r)-6,14-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@]4(O)[C@@H]3C[C@@H](O)C2=C1 UDHAKZRCGHAPAZ-NFBMXZEVSA-N 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- GTOWDLHXRPBZKU-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl.ClC(Cl)Cl GTOWDLHXRPBZKU-UHFFFAOYSA-N 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 229940085033 nolvadex Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62024595A JPS63192795A (ja) | 1987-02-06 | 1987-02-06 | ６β，１１α−ジヒドロキシ−４−アンドロステン−３，１７−ジオン |
| DE8888901462T DE3873200T2 (de) | 1987-02-06 | 1988-02-05 | Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung. |
| AT88901462T ATE78825T1 (de) | 1987-02-06 | 1988-02-05 | Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung. |
| EP88901462A EP0300062B1 (en) | 1987-02-06 | 1988-02-05 | Novel androst-4-ene-3,17-dione derivatives and process for their preparation |
| PCT/JP1988/000114 WO1988005781A1 (fr) | 1987-02-06 | 1988-02-05 | Nouveaux derives d'androst-4-ene-3,17-dione et procede de preparation |
| US07/279,596 US4975368A (en) | 1987-02-06 | 1988-09-26 | Novel androst-4-ene-3,17-dione derivatives and method for preparing same |
| US07/555,691 US5079377A (en) | 1987-02-06 | 1990-07-23 | Novel androst-4-ene-3,17-dione derivatives and method for preparing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62024595A JPS63192795A (ja) | 1987-02-06 | 1987-02-06 | ６β，１１α−ジヒドロキシ−４−アンドロステン−３，１７−ジオン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63192795A true JPS63192795A (ja) | 1988-08-10 |
| JPH0150716B2 JPH0150716B2 (cs) | 1989-10-31 |
Family
ID=12142506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62024595A Granted JPS63192795A (ja) | 1987-02-06 | 1987-02-06 | ６β，１１α−ジヒドロキシ−４−アンドロステン−３，１７−ジオン |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63192795A (cs) |
-
1987
- 1987-02-06 JP JP62024595A patent/JPS63192795A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0150716B2 (cs) | 1989-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08175990A (ja) | Ｐｉ３キナーゼ阻害剤とその製造法 | |
| CN104892622B (zh) | 嗜氮酮类化合物及其制备方法和用途 | |
| WO1991018003A1 (fr) | Derive antitumoral de be-13793c | |
| US5079377A (en) | Novel androst-4-ene-3,17-dione derivatives and method for preparing same | |
| JPS63192795A (ja) | ６β，１１α−ジヒドロキシ−４−アンドロステン−３，１７−ジオン | |
| JPS63192796A (ja) | ６β，１４α−ジヒドロキシ−４−アンドロステン−３，１７−ジオン | |
| US5789602A (en) | Physiologically active substances PF1092A, PF1092B and PF1092C, process for the production thereof, and contraceptives and anticancer drugs containing the same as active ingredients | |
| CN108992450A (zh) | 环黄芪醇衍生物在制备抗肝纤维化作用药物中的应用 | |
| JPH0256423A (ja) | ナフトピラン誘導体およびその用途 | |
| JP2622712B2 (ja) | ７α，１４α−ジヒドロキシ−アンドロスト−１，４−ジエン−３，１７−ジオン | |
| JP2689144B2 (ja) | ７〆，１１〆−ジヒドロキシーアンドロストー１，４−ジエン−３，１７−ジオン | |
| JPS63192794A (ja) | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン | |
| JP2622700B2 (ja) | １５β‐ヒドロキシ‐１９‐ノル‐テストステロン | |
| CN118994184B (zh) | 一种石斛碱小分子活性探针及制备方法 | |
| JP2003503412A (ja) | 海洋放線菌に由来する新規のインドロカルバゾールアルカロイド | |
| JPH01229000A (ja) | ２（３―ハイドロキシ―１，３，５（１０）―エストリエン―１７―イル）プロピオン酸の製造法 | |
| CN1331836C (zh) | 一种具有生物活性的c60反丁二酸及其合成方法 | |
| JP3380667B2 (ja) | 新規生理活性物質ｐｆ１０９２ａ物質、ｐｆ１０９２ｂ物質及びｐｆ１０９２ｃ物質，それらの製造法並びにそれらを有効成分とする避妊剤及び制癌剤 | |
| CN100582110C (zh) | 环己酮类饱和三环（桥环）化合物及其制备方法与用途 | |
| JPH01131177A (ja) | Ｎｆ−１６１６−９０４物質 | |
| JPS63192799A (ja) | ７β，１５β，１７α−トリヒドロキシ−４−プレグネン−３，２０−ジオン | |
| CN116694475A (zh) | 一种毛壳菌菌株及其发酵生产的具有神经保护活性的化合物 | |
| CN106432035A (zh) | 源于桔绿木霉的青霉烯醇e1在恶性黑色素瘤方面的应用 | |
| JPH01131193A (ja) | １４α−ヒドロキシ−アンドロスト−４−エン−３，６，１７−トリオンのエステル誘導体 | |
| JPS63192797A (ja) | ６β，１４α−ジヒドロキシ−△↑４−アンドロステン−３，１７−ジオン誘導体 |